BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 31122919)

  • 1. Susceptibility-Weighted MR Imaging Hypointense Rim in Progressive Multifocal Leukoencephalopathy: The End Point of Neuroinflammation and a Potential Outcome Predictor.
    Thurnher MM; Boban J; Rieger A; Gelpi E
    AJNR Am J Neuroradiol; 2019 Jun; 40(6):994-1000. PubMed ID: 31122919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical hypointensity in T2-weighted gradient-echo sequences in patients with progressive multifocal leukoencephalopathy.
    López Sala P; Alberdi Aldasoro N; Zelaya Huerta MV; Bacaicoa Saralegui MC; Cabada Giadás T
    Radiologia (Engl Ed); 2020; 62(1):59-66. PubMed ID: 31375267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pomalidomide-associated progressive multifocal leukoencephalopathy in multiple myeloma: cortical susceptibility-weighted imaging hypointense findings prior to clinical deterioration.
    Ueno H; Kikumto M; Takebayashi Y; Ishibashi H; Takahashi T; Yasutomi H; Umemoto K; Nakamichi K; Saijo M; Ichinohe T; Maruyama H
    J Neurovirol; 2020 Jun; 26(3):452-455. PubMed ID: 32394398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High b-value diffusion-weighted imaging in progressive multifocal leukoencephalopathy in HIV patients.
    Godi C; De Vita E; Tombetti E; Davagnanam I; Haddow L; Jäger HR
    Eur Radiol; 2017 Sep; 27(9):3593-3599. PubMed ID: 28168372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of quantitative susceptibility mapping (QSM) in progressive multifocal leukoencephalopathy.
    Carra-Dalliere C; Menjot de Champfleur N; Deverdun J; Ayrignac X; Nerrant E; Makinson A; Casanova ML; Labauge P
    J Neuroradiol; 2016 Feb; 43(1):6-10. PubMed ID: 26475668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of demyelinating lesions in progressive multifocal leukoencephalopathy (PML): Comparison of magnetic resonance images and neuropathology of post-mortem brain.
    Ono D; Shishido-Hara Y; Mizutani S; Mori Y; Ichinose K; Watanabe M; Tanizawa T; Yokota T; Uchihara T; Fujigasaki H
    Neuropathology; 2019 Aug; 39(4):294-306. PubMed ID: 31155757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-signal-intensity rim on susceptibility-weighted imaging is not a specific finding to progressive multifocal leukoencephalopathy.
    Umino M; Maeda M; Ii Y; Tomimoto H; Sakuma H
    J Neurol Sci; 2016 Mar; 362():155-9. PubMed ID: 26944139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain Magnetic Susceptibility Changes in Patients with Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.
    Hodel J; Outteryck O; Verclytte S; Deramecourt V; Lacour A; Pruvo JP; Vermersch P; Leclerc X
    AJNR Am J Neuroradiol; 2015 Dec; 36(12):2296-302. PubMed ID: 26316568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low signal intensity in U-fiber identified by susceptibility-weighted imaging in two cases of progressive multifocal leukoencephalopathy.
    Miyagawa M; Maeda M; Umino M; Kagawa K; Nakamichi K; Sakuma H; Tomimoto H
    J Neurol Sci; 2014 Sep; 344(1-2):198-202. PubMed ID: 24972818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors and characteristics of seizures in survivors of progressive multifocal leukoencephalopathy.
    Miskin DP; Herman ST; Ngo LH; Koralnik IJ
    J Neurovirol; 2016 Aug; 22(4):464-71. PubMed ID: 26676826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juxtacortical susceptibility changes in progressive multifocal leukoencephalopathy at the gray-white matter junction correlates with iron-enriched macrophages.
    Mahajan KR; Amin M; Poturalski M; Lee J; Herman D; Zheng Y; Androjna C; Howell M; Fox RJ; Trapp BD; Jones SE; Nakamura K; Ontaneda D
    Mult Scler; 2021 Dec; 27(14):2159-2169. PubMed ID: 33749379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Radiological Characterization of Progressive Multifocal Leukoencephalopathy in HIV-Infected Patients: A Retrospective Analysis and Review of the Literature.
    Augusto L; Neves N; Reis C; Abreu C; Sarmento A
    Acta Med Port; 2015; 28(3):286-96. PubMed ID: 26421780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma. A Case Report and Literature Review.
    Felli V; Di Sibio A; Anselmi M; Gennarelli A; Sucapane P; Splendiani A; Catalucci A; Marini C; Gallucci M
    Neuroradiol J; 2014 Dec; 27(6):657-64. PubMed ID: 25489887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI Shrimp Sign in Cerebellar Progressive Multifocal Leukoencephalopathy: Description and Validation of a Novel Observation.
    Adra N; Goodheart AE; Rapalino O; Caruso P; Mukerji SS; González RG; Venna N; Schmahmann JD
    AJNR Am J Neuroradiol; 2021 Jun; 42(6):1073-1079. PubMed ID: 33985948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical spectrum of progressive multifocal leukoencephalopathy: differences and similarities in patients with and without human immunodeficiency virus].
    Camporro J; Bruno V; Cammarota A; Del Castillo M; Alessandro L
    Rev Neurol; 2019 Aug; 69(4):152-158. PubMed ID: 31334558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for susceptibility weighted imaging in progressive multifocal leukoencephalopathy.
    Yap SM; Murray B; Lynch T; Kavanagh E; MacMahon P
    Ir Med J; 2017 Apr; 110(4):549. PubMed ID: 28665088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presumptive progressive multifocal leukoencephalopathy in multiple sclerosis after natalizumab therapy.
    Eisele P; Szabo K; Hornberger E; Griebe M; Hennerici MG; Kieseier BC; Gass A
    J Neuroimaging; 2014; 24(4):425-8. PubMed ID: 23323645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy.
    Dong-Si T; Gheuens S; Gangadharan A; Wenten M; Philip J; McIninch J; Datta S; Richert N; Bozic C; Bloomgren G; Richman S; Weber T; Clifford DB
    J Neurovirol; 2015 Dec; 21(6):637-44. PubMed ID: 25771865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy.
    Wattjes MP; Richert ND; Killestein J; de Vos M; Sanchez E; Snaebjornsson P; Cadavid D; Barkhof F
    Mult Scler; 2013 Dec; 19(14):1826-40. PubMed ID: 24192217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive multifocal leukoencephalopathy in HIV-infected patients in the era of HAART: radiological features at diagnosis and follow-up and correlation with clinical variables.
    Giancola ML; Rizzi EB; Lorenzini P; Rovighi L; Baldini F; Schininà V; Larussa D; Bibbolino C; Antinori A
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):155-62. PubMed ID: 18240958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.